DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
11,100
Employees11,100
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
11,100
Employees11,100

DXCM Key Statistics

Market cap
26.10B
Market cap26.10B
Price-Earnings ratio
32.44
Price-Earnings ratio32.44
Dividend yield
Dividend yield
Average volume
3.76M
Average volume3.76M
High today
High today
Low today
Low today
Open price
$68.38
Open price$68.38
Volume
0.00
Volume0.00
52 Week high
$89.98
52 Week high$89.98
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

The current DexCom(DXCM) stock price is $67.79, with a market capitalization of 26.1B. The stock trades at a price-to-earnings (P/E) ratio of 32.44.

On 2026-03-11, DexCom(DXCM) shares started trading at $68.38, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 3.76M.

Over the past 52 weeks, DexCom(DXCM) stock has traded between a high of $89.98 and a low of $54.11.

Over the past 52 weeks, DexCom(DXCM) stock has traded between a high of $89.98 and a low of $54.11.

DXCM News

TipRanks 2h
DexCom price target raised to $84 from $77 at Citi

Citi analyst Joanne Wuensch raised the firm’s price target on DexCom (DXCM) to $84 from $77 and keeps a Buy rating on the shares. The firm adjusted targets in t...

Simply Wall St 5d
Evaluating DexCom After Recent Share Price Weakness And Perceived 17.3% Undervaluation

Advertisement DexCom’s recent stock performance in focus DexCom (DXCM) has drawn attention after recent share price moves, with the stock down about 3% over t...

Evaluating DexCom After Recent Share Price Weakness And Perceived 17.3% Undervaluation

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
15.2%
Sell
3%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.